- Report
- August 2023
- 80 Pages
Brazil
From €1413EUR$1,500USD£1,208GBP
- Report
- August 2023
- 80 Pages
Argentina
From €1413EUR$1,500USD£1,208GBP
- Report
- November 2021
- 545 Pages
Global
From €3768EUR$4,000USD£3,222GBP
- Report
- November 2021
- 1165 Pages
Global
From €5652EUR$6,000USD£4,833GBP
- Report
- November 2021
- 233 Pages
Global
From €2355EUR$2,500USD£2,014GBP
- Book
- October 2020
- 288 Pages
Single Nucleotide Polymorphism (SNP) is a type of genetic variation that occurs when a single nucleotide in the genome sequence is altered. SNPs are the most common type of genetic variation among individuals and are used in genomics to identify genetic differences between individuals. SNP analysis is used to identify genetic markers associated with diseases, to study the genetic basis of complex traits, and to identify genetic variants associated with drug response.
SNP analysis is used in a variety of applications, including personalized medicine, pharmacogenomics, and population genetics. SNP analysis is also used in the development of diagnostic tests, drug discovery, and gene therapy. SNP analysis is also used in the development of genetic tests for disease risk assessment and in the development of genetic tests for disease diagnosis.
The SNP market is a rapidly growing market, driven by the increasing demand for personalized medicine and the development of new technologies for SNP analysis. Companies in the SNP market include Illumina, Thermo Fisher Scientific, BGI, and Genomics plc. Show Less Read more